Abstract PR03: CSF-1R Antibody Targeting Therapy with Combined Metronomic Chemotherapy and Immune Checkpoint Blockade Enhance a B and T Cell Response to Attenuate Metastatic Triple Negative Breast Cancer
Cancer Research（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要